Conmed (CNMD) Amortization - Intangibles (2010 - 2011)
Conmed posted quarterly Amortization - Intangibles of $565000.0 for Q4 2011, down 47.54% year-on-year from $1.1 million in Q4 2010, and down 50.04% on a QoQ basis from $1.1 million in Q3 2011.
Conmed (CNMD) has 2 years of Amortization - Intangibles data on file, last reported at $565000.0 in Q4 2011.
- For the quarter ending Q4 2011, Amortization - Intangibles fell 47.54% year-over-year to $565000.0; the trailing twelve-month figure through Sep 2012 stood at $565000.0 (down 87.2% YoY), and the FY2011 full-year result was $3.9 million, down 8.03% from the prior year.
- Amortization - Intangibles for Q4 2011 stood at $565000.0, down from $1.1 million in the prior quarter.
- Across five years, Amortization - Intangibles topped out at $1.1 million in Q3 2011 and bottomed at $565000.0 in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Conmed | 1.06 Bn | 1.02 Bn | 183.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 565,000.00 |
| Sep 30, 2011 | 1.13 Mn |
| Jun 30, 2011 | 1.11 Mn |
| Mar 31, 2011 | 1.09 Mn |
| Dec 31, 2010 | 1.08 Mn |
| Sep 30, 2010 | 1.06 Mn |
| Jun 30, 2010 | 1.06 Mn |